Estrogen- and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratory.
about
Estrogen receptor degradation: a CUE for endocrine resistance?Hormonal Modulation of Breast Cancer Gene Expression: Implications for Intrinsic Subtyping in Premenopausal WomenNew Robust and Reproducible Stereological IHC Ki67 Breast Cancer Proliferative Assessment to Replace Traditional Biased Labeling Index.American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancerCrowdsourcing the General Public for Large Scale Molecular Pathology Studies in Cancer.Fractionated evaluation of immunohistochemical hormone receptor expression enhances prognostic prediction in breast cancer patients treated with tamoxifen as adjuvant therapyPrognostic and predictive value of low estrogen receptor expression in breast cancerBreast Cancer Survival Defined by the ER/PR/HER2 Subtypes and a Surrogate Classification according to Tumor Grade and Immunohistochemical Biomarkers.Intratumor heterogeneity and precision of microarray-based predictors of breast cancer biology and clinical outcome.Basal keratin expression in breast cancer by quantification of mRNA and by immunohistochemistry.Distribution patterns of 21-gene recurrence score in 980 Chinese estrogen receptor-positive, HER2-negative early breast cancer patients.Genotype-guided tamoxifen therapy: time to pause for reflection?Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199.Prospective transGEICAM study of the impact of the 21-gene Recurrence Score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER+) node-negative breast cancer.Integrative proteomics and tissue microarray profiling indicate the association between overexpressed serum proteins and non-small cell lung cancerCYP2D6 inhibition and breast cancer recurrence in a population-based study in Denmark.Emerging trends in the treatment of triple-negative breast cancer in Canada: a survey.Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trialsStudy of Estrogen Receptor and Progesterone Receptor Expression in Breast Ductal Carcinoma In Situ by Immunohistochemical Staining in ER/PgR-Negative Invasive Breast CancerGenome-wide gene expression profiling of formalin-fixed paraffin-embedded breast cancer core biopsies using microarrays.Factors associated with concordant estrogen receptor expression at diagnosis and centralized re-assay in a Danish population-based breast cancer studyConstruction of tissue microarrays from core needle biopsies - a systematic literature review.Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approachA population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone.Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance between Immuno-Histochemistry and MapQuant™ Microarray Based Assay.Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast CancerHormone Receptor Expression Analyses in Neoplastic and Non-Neoplastic Canine Mammary Tissue by a Bead Based Multiplex Branched DNA Assay: A Gene Expression Study in Fresh Frozen and Formalin-Fixed, Paraffin-Embedded Samples.Multiplexed quantification of estrogen receptor and HER2/Neu in tissue and cell lysates by peptide immunoaffinity enrichment mass spectrometry.ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer.Quantitative analysis of estrogen receptor expression shows SP1 antibody is more sensitive than 1D5.Quantitative Gene Expression by Recurrence Score in ER-Positive Breast Cancer, by Age.Human epidermal growth factor receptor-2-positive breast cancer: does estrogen receptor status define two distinct subtypes?Prognostic value of biologic subtype and the 21-gene recurrence score relative to local recurrence after breast conservation treatment with radiation for early stage breast carcinoma: results from the Eastern Cooperative Oncology Group E2197 studyRelationship between quantitative GRB7 RNA expression and recurrence after adjuvant anthracycline chemotherapy in triple-negative breast cancer.Discordant assessment of tumor biomarkers by histopathological and molecular assays in the EORTC randomized controlled 10041/BIG 03-04 MINDACT trial breast cancer : Intratumoral heterogeneity and DCIS or normal tissue components are unlikely to be tPerformance of Three-Biomarker Immunohistochemistry for Intrinsic Breast Cancer Subtyping in the AMBER Consortium.Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapyLife history theory and breast cancer risk: methodological and theoretical challenges: Response to "Is estrogen receptor negative breast cancer risk associated with a fast life history strategy?".Practical implications of gene-expression-based assays for breast oncologists.Intratumoral heterogeneity as a source of discordance in breast cancer biomarker classification.
P2860
Q26830072-5E7AC758-09FA-4232-8D70-222492772967Q28077637-C5BEE8E1-45CD-4695-AA0F-B1804F17B302Q30489246-CA9FFCE9-962D-4C3F-BC94-61EFC2A45B82Q30494798-E1947342-3595-4337-9BC1-918D277E7562Q30660858-88405C8D-020D-4928-BDA6-727557EC831CQ33568902-ACC1DD9C-8689-47BC-BB72-40A7EBC775F8Q33611133-57D92CD8-5A22-4516-97F8-659487D0C596Q33757796-34D0037E-0439-453B-B2A7-D59597082BBCQ33813736-47AB1F05-EF0E-46B8-8C45-58C220DC95E1Q33864102-C6D90929-BC1B-42EE-B2E1-CEA7C7017A6FQ33888929-7E172CAF-8F9B-4868-B3D3-9DF4FAFB6D0FQ33955759-AEA6E9A4-BB4B-4C61-82B1-EBB3786FD5FCQ34172008-32DF1C61-B2A2-4193-9FDF-29E5A3BFF6FDQ34190743-AD309F05-986D-4CB1-BAF2-C1579B30201EQ34532251-AB48EC9B-A9E4-49BF-BEBE-1ED2945E9468Q34677193-681184A3-019A-429A-9C9F-F6D67F01ECC4Q35145663-C937D220-9974-49BC-9A23-F6ADC0652729Q35186747-2094A57D-0CFC-4454-B194-3CC50B45B75BQ35431358-6D8D315B-3D63-47A2-BFD6-9E095EB816F1Q35440724-409C4F82-3078-43E3-9F5E-BA4D79F4B756Q35690804-5C065478-7874-413D-B068-4B623DA0D624Q35743491-91627344-A844-42C3-9432-21D5BE43F96BQ35816286-ED847DA6-A80E-46C9-B2DF-45C5B5ED11F8Q35816292-6C2EA905-923B-40BA-BB87-C2710A93D957Q35909719-4D7B9B70-C390-4173-B533-6A23B2A116F1Q36092813-1C81874B-D495-495F-956E-B9006FE5432BQ36138577-0793298C-8BA1-4B54-B52D-DB2F9550047CQ36163327-4544847C-06AA-42D5-A91F-406CDBB024F2Q36245537-31F695C9-2590-4309-AC8A-3EEE7A286326Q36350762-0637CBF7-560A-4979-A2AD-266A74DB825FQ36373733-3AF711E7-F330-484D-85A9-B87F4C575B35Q36551617-A9559C96-A109-41A2-B4FB-7250AD67DE73Q36554725-17F81478-71A3-4CE4-BDFF-A925FC5C257FQ36603829-4FB81F77-DD58-4AFB-8A5B-79C3BCD1D0F7Q36610188-514B5C33-F44E-4509-BC68-1C4DDEF1C5BEQ36655887-D910DE7F-3E19-46BB-963F-C794E943C32BQ36793779-95FA1AE4-2031-4D1D-8A59-0B603ABE46D4Q36923548-E19DC2A0-5207-460B-B43F-D8269877E229Q36989546-6E9DDDC1-D32C-47CD-B19A-5E6F41AA9CF0Q37045365-C9D80318-EE2A-4987-BD4A-69254B2DD9E8
P2860
Estrogen- and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratory.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Estrogen- and progesterone-rec ...... eaction by central laboratory.
@en
Estrogen- and progesterone-rec ...... eaction by central laboratory.
@nl
type
label
Estrogen- and progesterone-rec ...... eaction by central laboratory.
@en
Estrogen- and progesterone-rec ...... eaction by central laboratory.
@nl
prefLabel
Estrogen- and progesterone-rec ...... eaction by central laboratory.
@en
Estrogen- and progesterone-rec ...... eaction by central laboratory.
@nl
P2093
P356
P1476
Estrogen- and progesterone-rec ...... eaction by central laboratory.
@en
P2093
Barrett H Childs
Edith A Perez
Frederick L Baehner
George W Sledge
Joseph A Sparano
Lawrence J Shulman
Lori J Goldstein
Mei-Lan Liu
Nancy E Davidson
Robert P Gray
P304
P356
10.1200/JCO.2007.13.6424
P407
P577
2008-05-01T00:00:00Z